TNF-Like Ligand 1 Aberrance Aggravates Nonalcoholic Steatohepatitis via M1 Macrophage Polarization
Nonalcoholic steatohepatitis (NASH) is a progressive, chronic liver disease worldwide which imposes a large economic burden on society. M1/M2 macrophage balance destruction and recruitment of mononuclear immune cells to the liver play critical roles in NASH. Several studies have shown that the expression of TNF-like ligand 1 aberrance (TL1A) increased in macrophages associated with many inflammatory diseases, for example, inflammatory bowel disease, primary biliary cholangitis, and liver fibrosis. One recent research showed that weight, abdominal adipose, and liver leptin, one of the critical fat cytokines, were reduced in TL1A knockout mice. However, the functional and molecular regulatory mechanisms of TL1A on macrophage polarization and recruitment in NASH have yet to be clarified. The authors found that high fructose high fat diet and methionine-choline deficiency diet induced the expression of TL1A in macrophages of liver tissue from murine NASH models. Myeloid-specific TL1A overexpressed mice showed exacerbated steatohepatitis with increased hepatic lipid accumulation, inflammation, liver injury, and apoptosis. M1 macrophages’ infiltration and the production of proinflammatory and chemotactic cytokines increased in liver of NASH mouse models with myeloid-specific TL1A overexpressed. Furthermore, this paper revealed that bone marrow-derived macrophages and Kupffer cells with overexpression of TL1A exacerbated the lipid accumulation and expression of proinflammatory factors in the murine primary hepatocytes after free fatty acid treatment in vitro. In conclusion, TL1A-mediated M1-type macrophage polarization and recruitment into the liver promoted steatohepatitis in murine NASH.
Nonalcoholic steatohepatitis (NASH) is an aggressive form of nonalcoholic fatty liver disease (NAFLD), which characterized by excessive fatty accumulation in liver, cell inflammation, and liver fibrosis. Ultimately, cirrhosis increases hepatocellular carcinoma (HCC) development risks [1, 2]. With the improvement of living standards and change of dietary habits, the morbidity of NASH gradually increases. Patients are younger. It has become a major healthcare burden worldwide [3, 4]. However, the pathogenesis of NASH is multifactorial and remains incompletely defined. Therefore, the investigation of NASH is of great necessity and significance.
According to “multiple-hit” hypothesis, which is thought to be the classical theory of NAFLD, oxidative stress and inflammation are the two pivotal mechanisms . As the key player of the innate immune system, macrophages play an important role in NASH by regulating inflammatory responses. Hepatocytes with redundant lipid accumulation could induce peroxidation to activate macrophages and promote M1 macrophage polarization. Macrophage polarization to M1 phenotype is associated with the production of proinflammatory cytokines, for example, tumor necrosis factor- (TNF-) α, interleukin- (IL-) 1β, and IL-6. Meanwhile, these proinflammatory cytokines could aggravate steatosis and promote apoptosis by inhibiting the outflow of cholesterol in hepatocytes. Proinflammatory macrophages could also recruit mononuclear macrophages expressed C-C chemokine receptor 2 (CCR2) and C-X-C chemokine receptor 2 (CXCR2) in the blood into the liver and accelerate inflammatory response by secreting C-C chemokine ligand 2 (CCL2) and chemokine C-X-C ligand 1 (CXCL1).
Several studies showed that TNF-like ligand 1 (TL1A), a member of the tumor necrosis factor superfamily (TNFSF) of ligands, was implicated in several autoimmune diseases, and its levels were elevated in macrophages [6–10]. In addition, Tougaard et al.  found that TL1A whole body knockout mice had a weight loss, decreased abdominal adipose tissue, and significantly decreased leptin expression in ileum and liver tissue. However, the role of TL1A-mediated regulation of macrophage polarization and recruitment in NASH is still unknown.
The authors found that the expression of TL1A was significantly increased in the livers of NASH murine models induced by high fructose high fat diets (HFHF) and methionine-choline deficiency (MCD) diets. Myeloid-specific TL1A overexpressed dramatically accelerated hepatic steatosis and M1-like phenotype macrophages infiltration in the liver. Moreover, bone marrow-derived macrophages (BMMs) and Kupffer cells (KCs) specific TL1A overexpressed promoted lipid accumulation and inflammatory factor secretion of nonalcoholic fatty hepatocytes in vitro.
2. Materials and Methods
The animal experiments were approved by Chinese Academy of Sciences Animal Care and Use Committee. Transgenic (Tg) mice with TL1A specific overexpression in myeloid cells were generated and genotyped as described  and provided by Cedars-Sinai Medical Center (America). They were bred and maintained in the specific pathogen-free condition at Experimental Animal Center of the Second Hospital of Hebei Medical University (China) and genotyped by real-time qPCR with tail DNA. At the same time, the littermate wild type (WT) mice were used as controls. Adult male mice of 6 ~ 8 weeks (weight: 18~21 g) were housed at and 12 h light/dark cycle with free access to water and food. The mice were fed with HFHF diets (76.5% normal chow, 12% lard, 1% cholesterol, 5% yolk powder, 5% whole milk powder, and 0.5% sodium cholate; Keao Xieli, China; 20% fructose, F8100, Solarbio, China) for 22 weeks, and a normal chow diet (Keao Xieli, China) for control. Besides, the MCD diet (A02082002B, Research Diets, USA) for 4 weeks was also used to construct the NASH model, and mice fed with methionine-choline-sufficient diet (A02082003B, Research Diets, USA) were regarded as controls.
2.2. Cell Culture
Bone marrow cells were isolated from the femur and tibia of WT and Tg mice, which were then incubated with macrophage colony-stimulating factor (M-CSF) for 10 days to differentiate BMMs. Afterwards, lipopolysaccharide (LPS) and interferon-γ (IFN-γ) were added into the culture medium to activate and differentiate BMMs into M1-like phenotype macrophages. Two days later, the medium as a conditional medium (CM) for hepatocytes culturing was collected.
KCs were harvested by liberase perfusion and differential centrifugation in Percoll . Procedures of cell differentiation are as follows. Cells were isolated by perfusion of the liver using collagenase type IV. The parenchymal cells were removed by centrifuging (). Nonparenchymal sufficient supernatant was centrifuged in a 60%/30% Percoll gradient. The KC-enriched fraction was adjusted to cells/mL and plated in plastic culture plates for 2 h in the incubator (37°C, 5% CO2). Afterwards, nonadherent cells were removed by replacing the culture medium with fresh complete medium. Similarly, LPS and IFN-γ were added to make KCs activate and differentiate into M1-like phenotype macrophages, and then, the CM was collected after two days.
Primary hepatocytes were isolated as previously described . Briefly, primary hepatocytes were isolated from the liver of male C57BL/6 mice by the collagenase perfusion method and then cultured in Dulbecco’s modified Eagle’s medium supplemented with 100 nmol/L dexamethasone and 1 g/mL insulin. The purity of hepatocytes detected by immunofluorescence staining was more than 90%. PA powder (P0500, Sigma-Aldrich, USA) and oleic acid (OA) (O1008, Sigma-Aldrich, USA) were dissolved in 0.1 M NaOH to make a stock solution, respectively. They were mixed at 2 : 1 as free fatty acid (FFA). To establish a cellular model of hepatic steatosis, the primary hepatocytes were exposed to an FFA mixture at a final concentration of 0.5 mM for 24 h. Finally, 50% CM from BMMs and KCs was used to incubate the nonalcoholic fatty hepatocytes.
2.3. Histological Analysis and Immunofluorescence Staining
Hematoxylin and eosin (H&E) staining and Oil red O staining were performed on paraffin-embedded and frozen liver sections, respectively. The expression of F4/80 (sc-52664, Santa Cruz, USA), TL1A (bs-5092R, Biosynthesis, China), Inducible Nitric Oxide Synthase (iNOS) (18985-1-AP, Proteintech, China), and CD206 (DF4149, Affinity, USA) was observed under confocal microscopy. The terminal deoxynucleotidyl transferase-dUTP nick end labeling (TUNEL) assay (C1086, Beyotime, China) was used to detect hepatocyte apoptosis.
2.4. Western Blot Analysis
TL1A (bs-5092R, Biosynthesis, China), CCR2 (DF7507, Affinity, USA), CXCR2 (DF7095, Affinity, USA), cleaved-caspase3 (AF7022, Affinity, USA), and cleaved-PARP1 (AF7023, Affinity, USA) were detected. The extraction of total protein was from liver tissues and macrophages. Equal amounts of total proteins were fractionated by SDS-PAGE, transferred onto polyvinylidene difluoride membranes, and then incubated with corresponding primary antibodies overnight at 4°C. Then, the membranes incubated with the secondary antibody, respectively, at 37°C for 1 hour.
2.5. Hepatic Lipid and Liver Function Assay
Liver function was evaluated in the serum and supernatant of hepatocytes by determining alanine aminotransferase (ALT) and aspartate aminotransferase (AST) using automatic biochemical analyzer (BECKMAN COULTER CX9, USA). Triglyceride (TG) and total cholesterol (TC) in liver tissue and primary hepatocytes were evaluated using the same analyzer.
2.6. Quantitative Real-Time PCR
Total mRNA from tissues and cells was extracted and then converted to cDNA (PC1802, Aidlab Biotechnologies, China). SYBR Green (FP205, TIANGEN, China) was used to perform quantitative real-time PCR amplification. The primers used in this study are presented in Supplemental Table 1.
2.7. Enzyme-Linked Immunosorbent Assay (ELISA) and Flow Cytometry
The TNF-α, IL-1β, IL-6, CCL2, and CXCL1 in serum and macrophage medium were measured using ELISA kits according to instructions of manufacturer (Multi Sciences, China). The antibody of F4/80 (11-4801-82), TNF-α (17-7321-82), pro-IL-1β (12-7114-82), and IL-6 (12-7061-82) and their isotype antibodies were all purchased from eBioscience and detected by FACS Verse flow-cytometer (BD Biosciences, USA). The specific steps were performed as previously reported . Annexin V/PI was also detected by flow cytometry using Dead Cell Apoptosis Kit (V13242, Invitrogen, USA) according to instructions of manufacturer.
2.8. Statistical Analysis
All statistical analysis was accomplished using the SPSS 22.0 software. Data was expressed as (). Differences between the two groups were determined using a two-tailed Student’s -test. Among multiple groups, differences were evaluated by one-way analysis of variance (ANOVA) followed by a Student-Newman-Keuls (SNK) post hoc test. values less than 0.05 were considered to be statistically significant in all.
3.1. TL1A Expression Is Upregulated in Liver Tissues and Macrophages of Mice with NASH
This paper evaluated the expression of TL1A in liver tissues and macrophages to explore the association between TL1A and NASH. For inducing steatohepatitis, adult male mice were fed HFHF diet for 22 weeks or MCD diet for 4 weeks. As shown in Figure 1(a1), the mRNA expression of TL1A in liver was upregulated in WT mice fed with HFHF diet compared with that in control mice ( vs. , ). HFHF-fed TL1A Tg mice had significantly higher TL1A expression than WT mice fed with the same diet ( vs. , , Figure 1(a1)). As it was expected, mice fed with MCD also displayed more TL1A mRNA compared to control mice (), especially in MCD-fed Tg mice (Figure 1(a2)). Consistently, the protein expression of TL1A in liver samples from NASH mice was higher than that in control mice (Figure 1(b)). In addition, the expression of TL1A was significantly increased in liver macrophages of Tg mice than WT mice in control diet groups by immunofluorescence of liver sections ( vs. , ), and the difference was more significant in HFHF-fed mice ( vs. , , Figures 1(c1) and 1(c2)). Consistent findings of elevated TL1A expression were confirmed using the MCD model (Figures 1(c3) and 1(c4)). Therefore, the authors reckoned that TL1A might participate in the pathology of NASH via hepatic macrophages.
3.2. Myeloid-Specific TL1A Overexpression Exacerbates Steatohepatitis
Myeloid-specific TL1A overexpressed Tg mice were used to investigate the effect of TL1A on liver injury and hepatocyte apoptosis. Compared to WT mice fed with HFHF or MCD, the significant steatohepatitis characterized by steatosis and inflammation was found in histological examination of liver sections of Tg mice fed with the same diet (Figure 2(a)). The increased hepatic steatosis in Tg mice with NASH compared to WT mice with NASH was confirmed by Oil Red O staining (Figure 2(b1)). Consistent with the pronounced steatosis seen from histology, hepatic cholesterol and hepatic triglyceride content was significantly higher in Tg mice with NASH compared to WT mice with NASH (Figures 2(b2)–2(b4)). In addition, serum alanine aminotransferase (ALT) and aspartic aminotransferase (AST) levels were markedly elevated in Tg mice fed with HFHF and MCD diet than WT counterparts (Figure 2(c)). Also, hepatocyte apoptosis was evaluated by TUNEL. It was found that hepatocyte apoptosis was significantly increased in HFHF-fed Tg mice compared to HFHF-fed WT mice (Figure 2(d1)). Consistent with the HFHF model, MCD-fed mice presented a similar result (Figure 2(d1)). Furthermore, these Western blot results were confirmed through detecting the protein of cleaved-caspase3 and cleaved-PARP (Figure 2(d2)). In summary, these results indicate that TL1A overexpression in myeloid cells exacerbates liver injury hepatocyte apoptosis in mice with NASH.
iNOS and CD206 are markers of M1 and M2 macrophages, respectively. To characterize macrophage subtypes responsible for regulating NASH pathogenesis by myeloid-specific TL1A overexpression, iNOS and CD206 mRNA levels were analyzed. As shown in Figure 3(a1), the expression of iNOS mRNA in HFHF-fed Tg mice was significantly higher than HFHF-fed WT mice ( vs. , , Figure 3(a1)). In contrast, the expression of CD206 mRNA was similar between HFHF-fed Tg mice and WT mice ( vs. , , Figure 3(a2)). The expression of iNOS and CD206 mRNA in MCD model was consistent with the HFHF model (Supplementary Figures 1(a1) and 1(a2)). Furthermore, we detected F4/80/iNOS and F4/80/CD206 by Immunofluorescence double staining, and the mean integral optical density (IOD) of coexpression areas was analyzed. Compared to WT mice fed with the HFHF diet, Tg mice fed with the same diet showed that the IOD of F4/80+/iNOS+ was higher than WT mice ( vs. , , Figures 3(b1) and 3(b3)). However, the IOD of F4/80+/CD206+ was not changed ( vs. , , Figures 3(b2) and 3(b4)). Similarly, the IOD of F4/80+/iNOS+ and F4/80+/CD206+ in the MCD model was consistent with the HFHF model (Supplementary Figure 1(b)). These results confirmed M1 macrophage polarization in TL1A Tg mice of NASH.
Given that TNF-α, IL-1β, and IL-6 are the main proinflammatory factors secreted by M1 macrophages, those were also detected by ELISA in serum, quantitative real-time PCR in liver tissues and flow cytometry in hepatic macrophages to verify myeloid-specific TL1A overexpression could polarize macrophages towards to M1 phenotype. The levels of TNF-α, IL-1β, and IL-6 were upregulation in serum, liver tissues, and hepatic macrophages of Tg mice fed with HFHF diet compared to WT mice fed with the same diet (Figures 3(c)–3(e)). In agreement with this result shown, higher levels of TNF-α, IL-1β, and IL-6 in the serum were found in Tg mice fed with MCD for 4 weeks and liver tissue as well as liver macrophages compared to WT mice fed with the same diet (Supplementary Figures 1(c)-1(e)). These results collectively suggested that myeloid-specific TL1A overexpression exacerbates liver injury and hepatocyte apoptosis partly through promoting M1 macrophage polarization.
3.3. Myeloid-Specific TL1A Overexpression Promotes the Recruitment of Macrophages into the Liver in Mice with NASH
We subsequently investigated the effect of myeloid-specific TL1A overexpression on macrophages recruitment. As shown in Figures 4(a) and 4(b), the expression of F4/80 detected by quantitative real-time PCR and immunofluorescent staining in liver of Tg mice fed with HFHF and MCD was significantly increased compared to WT mice fed with the same diet (Figures 4(a) and 4(b)). It is known that as the potent chemoattractant, CCL2 and CXCL1 recruit a large number of CCR2-positive and CXCR2-positive monocytes from the blood to enter the liver in steatohepatitis, respectively [16, 17]. Therefore, hepatic macrophage infiltration was evaluated by detecting CCL2/CCR2 and CXCL1/CXCR2. Increased CCL2/CCR2 and CXCL1/CXCR2 in liver tissues of HFHF-fed Tg mice were confirmed. Consistent with the HFHF model, increased chemokines and their receptors in Tg mice fed with MCD displayed severe infiltration (Figure 4(c)). These results suggested that myeloid-specific TL1A overexpression could enhance macrophage infiltration contributing to steatohepatitis in mice.
3.4. Macrophages with TL1A Overexpression Induce Lipid Accumulation, Proinflammatory Cytokine Production, and Apoptosis in Hepatocytes In Vitro
Here, we explored whether TL1A overexpressed macrophages with M1 polarization can accelerate the steatohepatitis changes of hepatocytes in vitro. The supernatant of BMMs and KCs isolated from Tg and WT mice was collected as a conditional medium. Combined with FFA, it was used to incubate primary hepatocytes isolated from WT mice. The quantification of supernatant ALT and AST levels in hepatocytes was significantly increased in the cultured medium of macrophages from Tg mice compared to the medium of macrophages from WT mice (Figures 5(a1) and 5(a2)). Consistently, lipid accumulation (Figure 5(b)) and proinflammatory cytokines (TNF-α, IL-1β, and IL-6) (Figure 5(c)) of hepatocytes were also markedly increased in the cultured medium of TL1A overexpressed macrophages as compared to the medium of WT macrophages. In addition, TL1A-overexpressed macrophages conditioned medium promoted hepatocyte apoptosis as detected by Annexin V/PI and c-caspase3/c-PARP (Figure 5(d)). Collectively, the above data revealed that macrophages with TL1A overexpression could reinforce lipid accumulation, proinflammatory cytokine secretion, and apoptosis in hepatocytes in vitro.
3.5. TL1A Involves in M1 Macrophage Polarization and Recruitment via Proinflammatory Cytokines
To assess whether TL1A could induce the polarization and recruitment of M1 macrophage, the cytokine profiles of the BMMs and KCs isolated from WT and Tg mice were analyzed. The expression of proinflammatory cytokines in macrophages was tested by quantitative real-time PCR and ELISA. As shown in Figure 6(a), TNF-α, IL-1β, and IL-6 were significantly increased in the BMMs from Tg mice compared to WT mice. Consistent with BMMs, the proinflammatory cytokines of KCs from Tg mice showed significantly higher than from WT mice. At the same time, the increased CCL2/CCR2 and CXCL1/CXCR2 in macrophages of Tg mice was also confirmed (Figure 6(b)). These results indicated that TL1A was involved in M1 macrophage polarization and recruitment through proinflammatory cytokines.
The trend of increasing numbers of NAFLD worldwide has been alarming in recent years . While NAFLD is mostly benign, NASH could lead to liver fibrosis and, ultimately, cirrhosis, increasing risks of hepatocellular carcinoma (HCC). It has been widely accepted that the M1/M2 balance of macrophages plays an important role in NASH. Intriguingly, the findings of this paper revealed a previously unknown function of TL1A in NASH pathogenesis by regulating M1 macrophages polarization, and it may be a new therapeutic target for the treatment of NAFLD. In this study, we found the enhanced expression of TL1A in liver tissues and macrophages using mouse models of NASH (Figure 1). Myeloid-specific TL1A overexpression increased the histological severity of steatohepatitis, lipid accumulation, and hepatocyte apoptosis. Our further observations showed that TL1A could promote the transformation of macrophages towards the M1 phenotype and the recruitment of macrophages into the liver in mice with NASH. These observations present the first evidence that TL1A might serve as a novel regulator in the pathogenesis of NASH.
TL1A involved in several immunological diseases, for example, rheumatoid arthritis, atherosclerosis, inflammatory bowel disease, and primary biliary cholangitis. Myeloid cells are one of the main mediators of TL1A. For instance, the authors also found that myeloid cells with TL1A overexpression induced the activation of macrophages and increased the secretion of inflammatory factors in liver fibrosis . Furthermore, the TL1A knockout mouse has a striking metabolic phenotype characterized by weight loss, decreased abdominal adipose tissue, and tissue expression of leptin . Currently, lots of studies have proved that TL1A plays a crucial role in regulating immunological disease, which includes the potential role of TL1A in the liver, especially in NAFLD. It needs further investigation at least under certain conditions. We found enhanced mRNA and protein expression of TL1A in liver tissues and macrophages under HFHF and MCD diet conditions. Furthermore, this study using myeloid-specific TL1A overexpression mice fed HFHF and MCD diets showed a decreased lipolysis and increased histological severity of steatohepatitis and hepatocyte apoptosis (Figure 2). These suggest that macrophage TL1A can contribute to hepatic steatosis, inflammation, and hepatocyte apoptosis.
Liver macrophage was identified as promoting the inflammation and fibrosis, as well as in the change from chronic damage to hepatoma . Portal macrophage infiltration was found in human subjects with steatosis, and the number of liver macrophages was associated with the severity of liver steatosis and inflammation . At the same time, KCs could initiate the liver inflammatory response by secreting inflammatory factors such as TNF-α and promote the recruitment of mononuclear macrophages to the liver to aggravate the liver inflammation in the mouse model of NASH . Furthermore, KC depletion could protect against the insulin resistance, steatosis, and production of proinflammatory cell infiltration in NASH rats .
Under pathological conditions, liver macrophages manifest heterogeneity like steatohepatitis. Macrophages have two distinct phenotypes: inflammatory (M1) macrophages marked by iNOS participate in antigen recognition secreting inflammatory cytokines and noninflammatory (M2) macrophages marked by CD206 which are involved in tissue repair and remodeling. M1 macrophages contribute to the production of inflammatory cytokines that associated with the pathogenesis of hepatic steatosis and inflammation in the liver [23, 24]. Given that overexpression of TL1A in macrophages led to accelerated steatohepatitis, we hypothesized that macrophage polarization was inclined to the M1 phenotype when TL1A was overexpressed in macrophage. To prove this hypothesis, the authors counted the density of M1 and M2 macrophages of liver tissues from WT and myeloid-specific TL1A overexpression mice and compared the expression of inflammatory cytokines in macrophages with TL1A overexpression and normal macrophages in vitro. Compared with WT mice fed with HFHF/MCD, increased hepatic M1 macrophage markers (iNOS, TNF-α, L-1β, and IL-6) and unchanged M2 macrophage marker (CD206) were found in HFHF/MCD-fed myeloid-specific TL1A overexpression mice, which further confirmed our hypothesis (Figure 3 and Figure S1). The results of proinflammatory cytokines in vivo experiment were consistent with in vitro assays (Figures 6(a1) and 6(a2)). To sum up, results mentioned above suggested that macrophage TL1A overexpression exacerbated steatohepatitis at least in part due to M1 polarization.
Moreover, it has been confirmed that most of the liver macrophages which play a leading role in NASH are from mononuclear macrophages derived from hematopoietic stem cells in the bone marrow that are recruited through the circulation . Once liver or intestinal fibrosis was formed, myeloid-specific TL1A overexpression mice showed more macrophages in the liver and intestine than WT mice [10, 12]. Similarly, the number of macrophages in hepatic tissues from Tg mice was significantly higher than that in WT mice. This result gave the evidence that the overexpression of TL1A in myeloid cells with NASH could contribute to recruitment of macrophages to liver. As efficient chemokines, CCL2 and CXCL1 could recruit a large number of CCR2 and CXCR1 positive mononuclear macrophages in the blood to enter liver. A large number of evidence have indicated that CCL2/CCR2 and CXCL1/CXCR2 played a critical role in recruiting macrophages into the liver in the progression of NAFLD [25–28].
Furthermore, TL1A knockout alleviated the expression of CXCL1 in the liver and ileum tissues and reduced the recruitment of inflammatory cells into the liver and ileum . In this study, we found upregulated CCL2/CCR2 and CXCL1/CXCR2 in HFHF-fed and MCD-fed Tg mice. The above findings from these animal experiments were further confirmed by in vitro assays. The chemokines and receptors were increased in primary macrophages isolated from myeloid-specific TL1A overexpression mice compared to WT mice (Figure 6(b)). Therefore, our data indicated that the promotion of TL1A promoted the recruitment of macrophages which might be via the upregulation of CCL2/CCR2 and CXCL1/CXCR2 expression.
In conclusion, we described the functional role of TL1A in macrophage polarization and the recruitment of macrophages into the liver, which promotes the progression of steatohepatitis. These findings shed new light on TL1A-targeted strategy of NAFLD therapy, although more extensive studies are required.
The data used to support the findings of this study are available from the corresponding author upon request.
Conflicts of Interest
The authors have no conflicts of interest to declare.
The authors acknowledge the support of Dr. Jun Yu (The Chinese University of Hong Kong) for mentoring the subject and Dr. Shuang Chen (Cedars Sinai Medical Center) for editing the manuscript. This work was supported by the Youth Fund Project of National Natural Science Foundation of China (81900522).
Supplemental Table 1: oligonucleotide sequences used for quantitative real-time PCR analysis. Supplemental Figure 1: myeloid-specific TL1A overexpression induces macrophages polarization to M1 phenotype in mice of MCD model. (Supplementary Materials)
Z. M. Younossi, G. Marchesini, H. Pinto-Cortez, and S. Petta, “Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation,” Transplantation, vol. 103, no. 1, pp. 22–27, 2019.View at: Publisher Site | Google Scholar
A. Mantovani, E. Scorletti, A. Mosca, A. Alisi, C. D. Byrne, and G. Targher, “Complications, morbidity and mortality of nonalcoholic c fatty liver disease,” Metabolism, vol. 111S, article 154170, 2020.View at: Google Scholar
Z. Younossi, F. Tacke, M. Arrese et al., “Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis,” Hepatology, vol. 69, no. 6, pp. 2672–2682, 2019.View at: Publisher Site | Google Scholar
I. Doycheva, K. D. Watt, and N. Alkhouri, “Nonalcoholic fatty liver disease in adolescents and young adults: the next frontier in the epidemic,” Hepatology, vol. 65, no. 6, pp. 2100–2109, 2017.View at: Publisher Site | Google Scholar
N. Tanaka, T. Kimura, N. Fujimori, T. Nagaya, M. Komatsu, and E. Tanaka, “Current status, problems, and perspectives of non-alcoholic fatty liver disease research,” World Journal of Gastroenterology, vol. 25, no. 2, pp. 163–167, 2019.View at: Google Scholar
Z. C. Yuan, J. M. Wang, L. C. Su, W. D. Xu, and A. F. Huang, “Gene polymorphisms and serum levels of TL1A in patients with rheumatoid arthritis,” Journal of Cellular Physiology, vol. 234, no. 7, pp. 11760–11767, 2019.View at: Publisher Site | Google Scholar
M. A. Cassatella, G. Pereira-da-Silva, I. Tinazzi et al., “Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis,” Journal of Immunology, vol. 178, no. 11, pp. 7325–7333, 2007.View at: Publisher Site | Google Scholar
J. E. McLaren, D. R. Michael, R. C. Salter et al., “The TNF-like protein 1A-death receptor 3 pathway promotes macrophage foam cell formation in vitro,” Journal of Immunology, vol. 184, no. 10, pp. 5827–5834, 2010.View at: Publisher Site | Google Scholar
Y. Aiba, K. Harada, A. Komori et al., “Systemic and local expression levels of TNF-like ligand 1A and its decoy receptor 3 are increased in primary biliary cirrhosis,” Liver International, vol. 34, no. 5, pp. 679–688, 2014.View at: Publisher Site | Google Scholar
J. Guo, Y. Luo, F. Yin et al., “Overexpression of tumor necrosis factor-like ligand 1 a in myeloid cells aggravates liver fibrosis in mice,” Journal of Immunology Research, vol. 2019, Article ID 7657294, 15 pages, 2019.View at: Publisher Site | Google Scholar
P. Tougaard, S. Skov, A. E. Pedersen et al., “TL1A regulates TCRγδ+ intraepithelial lymphocytes and gut microbial composition,” European Journal of Immunology, vol. 45, no. 3, pp. 865–875, 2015.View at: Publisher Site | Google Scholar
D. Q. Shih, R. Barrett, X. Zhang et al., “Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosis,” PLoS One, vol. 6, no. 1, article e16090, 2011.View at: Publisher Site | Google Scholar
B. Obrink, “26 Hepatocyte--collagen adhesion,” Methods in Enzymology, vol. 82, pp. 513–529, 1982.View at: Publisher Site | Google Scholar
K. L. Ma, X. Z. Ruan, S. H. Powis, Y. Chen, J. F. Moorhead, and Z. Varghese, “Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice,” Hepatology, vol. 48, no. 3, pp. 770–781, 2008.View at: Publisher Site | Google Scholar
J. Li, W. Shi, H. Sun et al., “Activation of DR3 signaling causes loss of ILC3s and exacerbates intestinal inflammation,” Nature Communications, vol. 10, no. 1, 2019.View at: Publisher Site | Google Scholar
K. Kazankov, S. M. D. Jørgensen, K. L. Thomsen et al., “The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis,” Nature Reviews. Gastroenterology & Hepatology, vol. 16, no. 3, pp. 145–159, 2019.View at: Publisher Site | Google Scholar
Y. S. Roh and E. Seki, “Chemokines and chemokine receptors in the development of NAFLD,” Advances in Experimental Medicine and Biology, vol. 1061, pp. 45–53, 2018.View at: Publisher Site | Google Scholar
A. J. Sanyal, “Past, present and future perspectives in nonalcoholic fatty liver disease,” Nature Reviews. Gastroenterology & Hepatology, vol. 16, no. 6, pp. 377–386, 2019.View at: Publisher Site | Google Scholar
F. Tacke, “Targeting hepatic macrophages to treat liver diseases,” Journal of Hepatology, vol. 66, no. 6, pp. 1300–1312, 2017.View at: Publisher Site | Google Scholar
V. L. Gadd, R. Skoien, E. E. Powell et al., “The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease,” Hepatology, vol. 59, no. 4, pp. 1393–1405, 2014.View at: Publisher Site | Google Scholar
A. C. Tosello-Trampont, S. G. Landes, V. Nguyen, T. I. Novobrantseva, and Y. S. Hahn, “Kuppfer Cells Trigger Nonalcoholic Steatohepatitis Development in Diet-induced Mouse Model through Tumor Necrosis Factor-α Production,” Journal of Biological Chemistry, vol. 287, no. 48, pp. 40161–40172, 2012.View at: Publisher Site | Google Scholar
M. Song, D. A. Schuschke, Z. Zhou et al., “Kupffer cell depletion protects against the steatosis, but not the liver damage, induced by marginal-copper, high-fructose diet in male rats,” American Journal of Physiology. Gastrointestinal and Liver Physiology, vol. 308, no. 11, pp. G934–G945, 2015.View at: Publisher Site | Google Scholar
S. S. Rensen, Y. Slaats, J. Nijhuis et al., “Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis,” The American Journal of Pathology, vol. 175, no. 4, pp. 1473–1482, 2009.View at: Publisher Site | Google Scholar
A. Jindal, S. Bruzzì, S. Sutti et al., “Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH),” Experimental and Molecular Pathology, vol. 99, no. 1, pp. 155–162, 2015.View at: Publisher Site | Google Scholar
H. Cynis, A. Kehlen, M. Haegele et al., “Inhibition of Glutaminyl Cyclases alleviates CCL2-mediated inflammation of non-alcoholic fatty liver disease in mice,” International Journal of Experimental Pathology, vol. 94, no. 3, pp. 217–225, 2013.View at: Publisher Site | Google Scholar
R. Parker, C. J. Weston, Z. Miao et al., “CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease,” American Journal of Physiology. Gastrointestinal and Liver Physiology, vol. 314, no. 4, pp. G483–G493, 2018.View at: Publisher Site | Google Scholar
W. K. Saeed, D. W. Jun, K. Jang et al., “Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease,” World Journal of Gastroenterology, vol. 24, no. 48, pp. 5477–5490, 2018.View at: Publisher Site | Google Scholar
K. Mukai, T. Miyagi, K. Nishio et al., “S100A8 production in CXCR2-expressing CD11b+Gr-1high cells aggravates hepatitis in mice fed a high-fat and high-cholesterol diet,” Journal of Immunology, vol. 196, no. 1, pp. 395–406, 2016.View at: Publisher Site | Google Scholar